Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania

Safety monitoring experience of single-low dose primaquine co-administered with artemether–lumefantrine among providers and patients in routine healthcare practice: a qualitative study in Eastern Tanzania

Abstract Background Primaquine is a gametocytocidal drug recommended by the World Health Organization (WHO) in a single-low dose combined with artemisinin-based combination therapy (ACT) for the treatment and prevention of Plasmodium falciparum malaria transmission. Safety monitoring concerns and th...

Full description

Bibliographic Details
Main Authors: Dominic Mosha, Mwaka A. Kakolwa, Muhidin K. Mahende, Honorati Masanja, Salim Abdulla, Chris Drakeley, Roland Gosling, Joyce Wamoyi
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Malaria Journal
Subjects:
Malaria
Primaquine
Artemether–lumefantrine
Safety
Monitoring
Online Access:https://doi.org/10.1186/s12936-021-03921-w

Internet

https://doi.org/10.1186/s12936-021-03921-w

Similar Items